Your browser doesn't support javascript.
loading
Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing.
Dallali, Hamza; Pezzilli, Serena; Hechmi, Meriem; Sallem, Om Kalthoum; Elouej, Sahar; Jmel, Haifa; Ben Halima, Yosra; Chargui, Mariem; Gharbi, Mariem; Mercuri, Luana; Alberico, Federica; Mazza, Tommaso; Bahlous, Afaf; Ben Ahmed, Melika; Jamoussi, Henda; Abid, Abdelmajid; Trischitta, Vincenzo; Abdelhak, Sonia; Prudente, Sabrina; Kefi, Rym.
Afiliação
  • Dallali H; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Pezzilli S; National Institute of Applied Sciences and Technology, University of Carthage, Tunis, Tunisia.
  • Hechmi M; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Sallem OK; Department of Experimental Medicine, Sapienza University, Rome, Italy.
  • Elouej S; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Jmel H; National Institute of Applied Sciences and Technology, University of Carthage, Tunis, Tunisia.
  • Ben Halima Y; Fattouma Bourguiba University Hospital, Monastir, Tunisia.
  • Chargui M; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Gharbi M; Faculty of Medicine La Timone, INSERM, GMGF, Aix Marseille University, 27 bd Jean Moulin, 13385, Marseille, France.
  • Mercuri L; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Alberico F; Faculty of Sciences of Bizerte, University of Carthage, Tunis, Tunisia.
  • Mazza T; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Bahlous A; University of Tunis El Manar, El Manar I, 2092, Tunis, Tunisia.
  • Ben Ahmed M; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Jamoussi H; Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Abid A; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Trischitta V; Research Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Abdelhak S; Unit of Bioinformatics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Prudente S; Central Laboratory of Medical Biology, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
  • Kefi R; Laboratory of Transmission, Control and Immunobiology of Infections, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, 1002, Tunis, Tunisia.
Acta Diabetol ; 56(5): 515-523, 2019 May.
Article em En | MEDLINE | ID: mdl-30656436
ABSTRACT

AIMS:

Maturity Onset Diabetes of the Young (MODY) is a monogenic form of diabetes with autosomal dominant inheritance pattern. The diagnosis of MODY and its subtypes is based on genetic testing. Our aim was investigating MODY by means of next-generation sequencing in the Tunisian population.

METHODS:

We performed a targeted sequencing of 27 genes known to cause monogenic diabetes in 11 phenotypically suspected Tunisian patients. We retained genetic variants passing filters of frequency in public databases as well as their probable effects on protein structures and functions evaluated by bioinformatics prediction tools.

RESULTS:

Five heterozygous variants were found in four patients. They include two mutations in HNF1A and GCK that are the causative genes of the two most prevalent MODY subtypes described in the literature. Other possible mutations, including novel frameshift and splice-site variants were identified in ABCC8 gene.

CONCLUSIONS:

Our study is the first to investigate the clinical application of targeted next-generation sequencing for the diagnosis of MODY in Africa. The combination of this approach with a filtering/prioritization strategy made a step towards the identification of MODY mutations in the Tunisian population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sequenciamento de Nucleotídeos em Larga Escala Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sequenciamento de Nucleotídeos em Larga Escala Idioma: En Ano de publicação: 2019 Tipo de documento: Article